PARANEOPLASTIC PEMPHIGUS

This adverse event was reported 130 times

PARANEOPLASTIC PEMPHIGUS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-6 Antagonist [EPC] 1 0.0015
1 CD30-directed Immunoconjugate [EPC] 2 0.0002
2 Antimalarial [EPC] 2 0.0002
3 Antiprotozoal [EPC] 2 0.0002
4 Sulfone [EPC] 2 0.0002
5 Human Immunoglobulin G [EPC] 3 0.0001
6 Adenosine Receptor Agonist [EPC] 1 0.0001
7 Alkylating Drug [EPC] 27 0.0001
8 CD20-directed Cytolytic Antibody [EPC] 34 0.0001
9 Lipid-based Polyene Antifungal [EPC] 1 0.0001
See all drug classes enriched for association with PARANEOPLASTIC PEMPHIGUS